M
Monopar Therapeutics Inc.
MNPR · NASDAQ · Healthcare · 757M
Price · close
$107.72
-2.85% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
5.8×
Enterprise value / EBITDAEV/EBITDA
-53.7×
Free cash flow yieldFCF yield
-1.5%
Return on equityROE
-10.0%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
4.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.